Clinical Research Directory
Browse clinical research sites, groups, and studies.
Curcumin and Retinal Study
Sponsor: Texas Tech University Health Sciences Center
Summary
To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.
Official title: Curcumin and Retinal Amyloid-beta Pilot Study
Key Details
Gender
All
Age Range
40 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-08-21
Completion Date
2026-12-31
Last Updated
2026-01-13
Healthy Volunteers
Yes
Conditions
Interventions
Low curcumin group
One curcumin capsule (250 mg curcumin) after each meal, 3 times a day for 2 weeks.
High curcumin group
One curcumin capsule (500 mg curcumin) after each meal, 3 times a day for 2 weeks.
Locations (1)
Texas Tech University Health Sciences Center
Lubbock, Texas, United States